advertisement
Multiple Sclerosis Research News
July 24, 2023

Top Headlines

Treatment at the First Signs of MS Could Mean Lower Risk of Disability Later

People who start taking medication soon after the first signs of multiple sclerosis (MS) may have a lower risk of disability later, according to a new ...

Oral Medication Is the Leading Choice for Multiple Sclerosis Treatment

Two injectable therapies accounted for nearly 100 percent of medications for patients in 2001, but by 2020 that decreased to about 25 ...

Multiple Sclerosis: New Biomarker Confirmed for Early Diagnosis

A study has demonstrated for the first time that diagnosis of multiple sclerosis (MS) can be significantly improved by additionally measuring the thickness of retinal layers in the eye. Use of the procedure helps to detect the condition at an earlier stage and predict its progression more ...

Genetic Variant Linked With Faster Progression of Multiple Sclerosis

的研究与多个年代超过22000人clerosis (MS) has for the first time identified a genetic variant associated with faster progression of the disease, an accumulation of disability that can rob patients of their mobility and independence over time. Multiple sclerosis begins as an ...
advertisement

Latest Headlines
updated 6:29pm EDT

Earlier Headlines

Immune System Reboot in MS Patients

Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study has now examined in detail the way in which the treatment curbs the autoimmune disease and ...

Researchers Offer Roadmap for Identifying New Neuroprotective Treatments by Leveraging Sex Differences

Sex differences in the aging brain may offer an enticing clue for developing more effective neuroprotective treatments, according to a new research ...

Tofacitinib Shows Promise in Scleroderma Patients, Researchers Optimistic for Next Phase of Study

The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes. Researchers say the drug is safe and ...

Study Advances Knowledge of Role of Brain Pathology and Cognitive Fatigue in Multiple Sclerosis

Researchers demonstrate the relationship between the rate of cognitive fatigue in MS and microstructural brain changes. The findings promise to advance development of clinical interventions for ...

Fish to Help in Search for MS Drugs

The zebrafish serves as a model organism for researchers around the world: it can be used to study important physiological processes that also take place in a similar form in the human body. It is ...

Simple Blood Test Predicts Neurotoxic Complications of CAR-T Cell Therapy

A new study suggests a simple blood test -- administered before CAR-T cell treatment is initiated -- may identify which patients are predisposed to developing neurotoxic side effects in the days and ...

advertisement

Health Care Spending May Help Explain Link Between Multiple Sclerosis and Latitude

Researchers have known people who live farther from the equator are more likely to develop multiple sclerosis (MS) and have often attributed that to vitamin D exposure. But countries farther from the ...

Quality of Life With Multiple Sclerosis May Depend on Several Factors

Quality of life is a measure of a person's level of comfort, health and happiness. For people with multiple sclerosis (MS), a new study has found there are specific factors that may affect a ...

Multiple Sclerosis Drug Works in a Surprising Way

Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding ...

Virtual Reality Technology Could Strengthen Effects of Traditional Rehabilitation for Multiple Sclerosis

By increasing sensory input and promoting multisensory processing, virtual reality may increase the effectiveness of traditional cognitive rehabilitation and exercise training in individuals with MS, ...

Harnessing the Immune System to Treat Traumatic Brain Injury in Mice

Researchers have designed a targeted therapeutic treatment that restricts brain inflammation. The effectiveness of this approach in improving outcomes was demonstrated following brain injury, stroke ...

Uncovering New Details of the Brain's First Line of Defense

A research team has mapped out the development and genetic trajectory of previously understudied macrophages associated with the central nervous system. Among other things, the team found that ...

advertisement

Multiple Sclerosis: Glatiramer Acetate Compatible With Breastfeeding, Study Suggests

For patients suffering from multiple sclerosis (MS), becoming a mother is fraught with difficult questions: is it acceptable to continue disease modifying treatment during pregnancy and breastfeeding ...

Findings Open Way for Personalized MS Treatment

目前vailable therapies to treat multiple sclerosis (MS) lack precision and can lead to serious side effects. Researchers have now developed a method for identifying the immune cells involved ...

A New Treatment Reduces Inflammation in Multiple Sclerosis Mice Models

Researchers managed to reduce chronic inflammation associated with multiple sclerosis in mice thanks to the administration of a type of lipid that mediates ...

Could Releasing ‘handbrake’ Immune Cells Help Supercharge Immunity?

Researchers have found a way to supercharge immune cells that could enable them to clear disease and infections ...

Total Economic Burden of MS in United States Is More Than $85 Billion

The estimated cost of multiple sclerosis (MS) reached $85.4 billion in 2019 in the United States, according to a new report. In addition, when researchers compared people with MS to people without MS ...

Behavioral Treatment for Deficits of Facial Affect Recognition in Multiple Sclerosis

A recent study has demonstrated efficacy for the behavioral intervention, EMOPRINT, for treating deficits of facial recognition in individuals with multiple sclerosis (MS). The study provides Class I ...

Researchers Develop New Antibody Test to Diagnose Multiple Sclerosis

Researchers have validated a new antibody test to diagnose multiple sclerosis (MS), a potentially disabling disease of the brain and spinal ...

Research Suggests Interrupting Immune Response Improves Multiple Sclerosis Outcomes

Multiple sclerosis is a chronic disease that damages neurons. New research looks at the role that a protein, STAT5, plays in the development of ...

Thursday, November 10, 2022
Friday, November 4, 2022
Thursday, October 6, 2022
Tuesday, September 20, 2022
Thursday, September 1, 2022
Wednesday, August 24, 2022
Wednesday, August 10, 2022
Wednesday, July 6, 2022
Thursday, May 26, 2022
Friday, May 20, 2022
Wednesday, May 11, 2022
Wednesday, April 27, 2022
Tuesday, April 26, 2022
Thursday, April 14, 2022
Wednesday, April 13, 2022
Tuesday, April 12, 2022
Thursday, March 24, 2022
Tuesday, March 22, 2022
Friday, March 4, 2022
Tuesday, March 1, 2022
Friday, February 18, 2022
星期三,2022年2月16日
Friday, January 28, 2022
Thursday, January 27, 2022
Tuesday, January 18, 2022
Thursday, January 13, 2022
Monday, January 10, 2022
Thursday, January 6, 2022
Monday, December 20, 2021
Wednesday, December 8, 2021
Tuesday, November 30, 2021
Friday, November 5, 2021
Thursday, November 4, 2021
Monday, October 18, 2021
Thursday, September 30, 2021
Wednesday, September 22, 2021
Thursday, September 9, 2021
Thursday, August 19, 2021
Thursday, August 12, 2021
Tuesday, July 13, 2021
Wednesday, June 16, 2021
Monday, June 7, 2021
Thursday, June 3, 2021
Tuesday, March 16, 2021
Tuesday, March 9, 2021
Wednesday, March 3, 2021
Wednesday, February 17, 2021
Wednesday, February 3, 2021
Friday, January 22, 2021
Tuesday, January 19, 2021
Wednesday, January 13, 2021
Saturday, January 9, 2021
Thursday, December 17, 2020
Friday, November 13, 2020
Thursday, October 22, 2020
Wednesday, October 7, 2020
Wednesday, August 26, 2020
Monday, August 17, 2020
Thursday, August 13, 2020